HALIX News and Resources

HALIX, a global healthcare Contract Development and Manufacturing Organization (CDMO), has introduced HALiXPEDITE, a new platform designed to fast-track biologics-based therapies to First-in-Human (FiH) trials. The platform was officially unveiled at the Innovation for Health conference in Rotterdam. The new

Rocketvax AG, a Swiss biotech leader, has teamed up with HALIX B.V., a top-tier Contract Development and Manufacturing Organization (CDMO), to bolster global pandemic readiness. The partnership will leverage Rocketvax’s innovative VIRUFLEX platform, designed to accelerate vaccine development in response